Full data view for gene MSH2


MSH2 variants classified by the InSiGHT consortium: criteria used for classification are available here. We encourage submission of relevant unpublished information to assist in the classification of variants via LOVD or this template which can be emailed to the curator.
Information The variants shown are described using the NM_000251.2 transcript reference sequence.

24 entries on 1 page. Showing entries 1 - 24.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - contributed by Dept. of Dr Vaccaro - - Germline - - - - - DNA SEQ - - ? - contributed by Dept. of Dr Vaccaro - - - Argentina - - - - - 1 CEMIC - Genotyping - Angela Solano
+/+ 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 Insight class: 5 InSiGHT - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - PubMed: Thompson 2013 - - Germline - - - - - DNA SEQ - - ? - - - - - - - - - - - 1 Mark Jenkins
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - PubMed: Loader 2005 - - Germline - - - - - DNA ? - - ? - - - ? - - - - - - - 1 Michael Woods
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - PubMed: Ollila 2006 - - Germline - - - - - DNA ? - - ? - - - ? - - - - - - - 1 Michael Woods
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Chao 2008 - - Unknown - - - - - DNA SEQ - - - - - - ? - - - - - - - 1 Rolf Sijmons
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Chao 2008 - - Unknown - - - - - DNA SEQ - - - - - - ? - - - - - - - 1 Rolf Sijmons
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Chao 2008 - - Unknown - - - - - DNA SEQ - - - - - - ? - - - - - - - 1 Rolf Sijmons
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - Unknown - - - - - DNA SEQ - - - - - - ? - - - - - - - 1 Rolf Sijmons
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - Unknown - - - - - DNA SEQ - - - - - - ? - - - - - - - 1 Rolf Sijmons
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - PubMed: Kohonen-Corish 2005 - - Germline - - - - - DNA ? - - ? - - - ? - - - - - - - 1 Michael Woods
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A Gly161Arg - MSH2_000293 - PubMed: Bianchi 2007 - - Germline - - - - - DNA ? - - ? - - - ? - - - - - - - 1 Michael Woods
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 Functional analysis indicated the protein was expressed in significantly lower amounts than the wild type protein and was associated with an altered subcellular localization. As well, SIFT software predicted this variant to be deleterious. PubMed: Belvederesi 2008 - - Germline - - - - - DNA ? - - ? - - - ? - - - - - - - 1 Michael Woods
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - pathogenic g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - Germline - - - - - DNA SEQ - - HNPCC (Lynch) - - 6 affected patients in this HNPCC family, mean age at onset: 52 years old;InSiGHT LOVDv2 ID:1008299; F - Germany - - - - - 1 Peter Propping, Prof. Dr. med.
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A 484G>A - MSH2_000293 - Liliana Varesco - - Germline - - - - - DNA SEQ - - cancer, bladder - - - M - - - - - - - 1 INSiGHT group
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A 484G>A - MSH2_000293 - Liliana Varesco - - Germline - - - - - DNA SEQ - - ? - - - M - - - - - - - 1 INSiGHT group
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A Exon 3 484G>A p.Gly162Arg Likely Path? - MSH2_000293 - Desiree du Sart - - Germline - - - - - DNA SEQ - - cancer, endometrial - - - - - - - - - - - 1 INSiGHT group
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A Exon 3 484G>A p.Gly162Arg Likely Path? - MSH2_000293 - Desiree du Sart - - Germline - - - - - DNA SEQ - - ? - - - - - - - - - - - 1 INSiGHT group
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A MSH2:484G>A (p.Gly162Arg) - MSH2_000293 - Adrienne Sexton, Kirsty Mann - - Germline - - - - - DNA SEQ - - ? - - Normal MLH1/MSH6 by seq & MLPA. Normal EPCAM&MSH2 MLPA. Sib dx CRC adenomas, IHC normal in 2 polyps tested, blood NEG for MSH2 UV;InSiGHT LOVDv2 ID:1016495;; Proband dx malignant polyp 50y. Sibling dx CRC 44y (overseas). Parent died 50y unknown cause. 3rd deg rel dx stomach 33y. - - - - - - - - 1 INSiGHT group
+/. 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A 484G>A - MSH2_000293 WT MaxEntScan score: 6.25; Variant MaxEntScan score: 6.25; Difference in MaxEntScan score between variant and WT (%): 0 InSiGHT, PubMed: Rossi 2017 - - Germline - - - - - DNA ? - - ? - InSiGHT, PubMed: Rossi 2017 A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America - - Argentina - - - - - 1 Mev Dominguez Valentin
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - NA g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - NA g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 3 c.484G>A r.484g>a p.Gly162Arg Unknown - NA g.47637350G>A g.47410211G>A G162R - MSH2_000293 {GR:108} PubMed: Ollila 2006 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/+ 3 c.484G>A r.(?) p.(Gly162Arg) Unknown - pathogenic g.47637350G>A g.47410211G>A - - MSH2_000293 - - - - Germline/De novo (untested) - - - - - DNA SEQ - year test performed: 2011 ? - - FH breast, stomach; F - (United Kingdom (Great Britain)) - - - - - 1 Treena Cranston
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.